Afficher la notice abrégée

Legal framework of antimicrobial stewardship in hospitals (LEASH): a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) cross-sectional international survey

dc.rights.licenseopenen_US
dc.contributor.authorBEOVIC, B.
dc.contributor.authorPULCINI, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDUMARTIN, Catherine
dc.contributor.authorBERAUD, G.
dc.contributor.authorNERAT, B.
dc.contributor.authorMAUREL, C.
dc.contributor.authorDOUSAK, M.
dc.contributor.authorCIZMAN, M.
dc.date.accessioned2020-10-20T07:05:02Z
dc.date.available2020-10-20T07:05:02Z
dc.date.issued2018-11
dc.identifier.issn1872-7913 (Electronic) 0924-8579 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/11447
dc.description.abstractEnAntimicrobial stewardship (AMS) is the cornerstone activity in the combat against antimicrobial resistance. In order to ensure sustainable deployment and development of AMS, a strategic and regulatory framework needs to be provided by national healthcare authorities. Experts from 32 European countries, Israel and Turkey were invited to participate in a cross-sectional internet-based survey from October 2016 to May 2017 on legal framework and mandatory components (structures, activities) of AMS in hospitals, i.e. components required by legislation or regulations. We collected data from 25 countries and two regions (in countries with federal health administration). Laws regulating AMS existed in seven countries and one region. Other health ministry regulations were applicable in 13 countries and one region. National strategies and/or action plans approved by ministries of health were in place in 13 countries and one region. On the other hand five countries and one region had no regulation of AMS in hospitals. Funding for AMS in hospitals was provided in five countries and one region. Eight countries and one region reported mandatory AMS structures and activities complying with the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) structure, policy and practice indicators. In 10/27 cases however, the mandatory AMS activities were not being fully carried out. The survey showed heterogeneous legal frameworks for AMS in hospitals, and in many countries it was even lacking. The situation may be critical in countries with poor control of antimicrobial use and resistance. Recent international initiatives calling on policy-makers to address the threat of AMR could yield improvement.
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.title.enLegal framework of antimicrobial stewardship in hospitals (LEASH): a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) cross-sectional international survey
dc.title.alternativeInt J Antimicrob Agentsen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.ijantimicag.2018.07.019en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30064000en_US
bordeaux.journalInternational journal of antimicrobial agentsen_US
bordeaux.page616-621en_US
bordeaux.volume52en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International%20journal%20of%20antimicrobial%20agents&rft.date=2018-11&rft.volume=52&rft.issue=5&rft.spage=616-621&rft.epage=616-621&rft.eissn=1872-7913%20(Electronic)%200924-8579%20(Linking)&rft.issn=1872-7913%20(Electronic)%200924-8579%20(Linking)&rft.au=BEOVIC,%20B.&PULCINI,%20C.&DUMARTIN,%20Catherine&BERAUD,%20G.&NERAT,%20B.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée